PLEASE NOTE:
For more congress presentations, please see also the VIDEO Section:
in English language
in German language

ESC Congress (European Society of Cardiology)
Munich, 29th of August 2018
Best Poster: M. Keller, M. Rippel, S. Silber:
Side effects of regadenoson replacing adenosine for pharmacological stress tests in real world: prospective evaluation in over 5000 patients
Abstract

ESC Congress (European Society of Cardiology)
Munich, 25th of August 2018
Oral Presentation Prof. Silber
Congress Condensed: Coronary Heart Disease
Program

American College of Cardiology (ACC)
Orlando, 11th of March 2018
IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS
JACC March 20, 2018 Volume 71, Issue 11
Abstract
Poster

18. Annual Congress of NFIC (New Frontiers in Interventional Cardiology)
Krakow, 7th and 8th of December, 2017
Chairman and Oral Presentation Prof. Silber:
Usefulness of pharmacological stress tests with Regadenosone: Experience in over 4000 patients in a cardiology practice in Germany
Program
Letter of Appreciation

Annual Congress of the CIAT
(Cardiovascular Intervention Association of Thailand)
Bangkok, 18th of November 2017
Oral Presentation Prof. Silber:
Should all DAPTs post PCI be new P2Y12 ?
Program

TCT Congress, Denver, Colorado
29th of October - 2nd of November 2017
Chairman and Oral Presentation Prof. Silber:
Promus Element Everolimus-Eluting Stents: Device Iterations
and Randomized/Registry Outcomes Data in Perspective
Program

Annual Congress of the European Society of Cardiology (ESC)
Barcelona, 30th of August 2017
Oral Presentation Prof. Silber:
Congress Condensed - General Cardiology
Coronary Artery Disease
Program

Great Minds - Expert Meeting
Budapest, June 23rd 2017
Presentation Prof. Silber:
Old and New Effective Strategies for LDL-Cholesterol Reduction
(Video Duration: 18:46)

EuroPCR Kongress
Paris, 17.th of May 2017
Poster Presentation: Okada K, Cutlip DE, Barakat M, Silber S, Erglis A, Honda Y on behalf of the COBRA PzF SHIELD Investigators
Final Optical Coherence Tomography Results from the COBRA PzF SHIELD Trial
Poster

International Conference on Nuclear Cardiology and Cardiac CT (ICNC)
Vienna, 9th of May 2017
Poster Presentation: Dr. med. M. Keller and Prof. Dr. S. Silber:
High Safety of Regadenoson for Myocardial Perfusion Imaging in a Cardiology Practice: Experience in over 4000 Patients
Poster

TCT Congress, Washington, DC
November 1st 2016
Presentation Prof. Silber:
Didactic Session: The TCT Late Breaking Trials:
Highlights – and my Interpretations – from:
BIO-RESORT (TWENTE III) and BIONICS
(Video Duration: 7:34)

• Presentation as ppt file (8 MB)
• Discussion of the Presentation:
  (Duration: 12:54)

TCT Congress, Washington, DC
October 31st 2016
Presentation Prof. Silber:
Can Passive Coatings Make a Difference?
Results With the COBRA PzF NanoCoated Coronary Stent 
(ppt file, 3,5MB)

Presentation as Video, (Duration: 6:45)

ESC Congress (European Society of Cardiology)
Rome, August 2016

Presentation:
Nightmares in Clinical Practice:
To stop or not to stop antiaggregation and or anticoagulation before a procedure

​​(Video, Duration: 19:22)

Presentation:
Take Home Message for the Practitioner:
Coronary Heart Disease

Video (Duration: 10:46)

Poster:
R. Piccolo, A. Franzone, K. Koskinas, L. Raeber, T. Pilgrim, M. Valgimigli, S. Stortecky, J. Rat-Wirtzler, S. Silber, P. Juni, D. Heg, S. Windecker
Diabetes and time course of adverse events in patients with acute coronary syndromes undergoing percutaneous coronary intervention

Annual Meeting of the German Society of Cardiology (DGK)
J.-N. Boeckel, L. Palapies, J. Klotsche, T. Zeller, B. von Jeisen, L. Pieper, S. Tzikas, D. Leistner, C. Bickel, G. K. Stalla, H. Lehnert, S. Silber, S. Baldus, W. März, S. Dimmeler, S. Blankenberg, T. Münzel, A. M. Zeiher, T. Keller
Presentation: A new method to adjust Troponin I accounting for the confounders age, gender and kidney function facilitates clinical interpretation in patients with chest pain
Mannheim, April 2nd 2016

ESC Congress (European Society of Cardiology)
Piccolo R, Heg D, Rat, Franzone JA, Silber S, Serruys PW, Pigrim T, Juni P, Windecker S.
Comparative effectiveness and safety of new versus early generation drug-eluting stents according to the complexity of coronary artery disease. A patient level pooled analysis of 6,081 patients
download presentation
download abstract, European Heart Journal ( 2015 ) 36 ( Abstract Supplement ), 29
London, 29. August 2015

Fajadet J, Garcia E, Neumann FJ, Hildick-Smith D,  Petronio S, Spence M, Wöhrle J,  Zaman A, Elhadad S, Silber S
on behalf of the Platinum Plus Trial Investigators
Results of the Primary Endpoint of the Platinum Plus Trial:
A Prospective, Randomized, Multi-center Trial to Assess the Everolimus Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients
1 year results
TCT (Transcatheter Cardiovascular Therapeutics) 
San Francisco, Oktober 2013
Power Point Presentation

Symposium:
JIM - Joint Interventional Meeting
Presentations:

• The RESOLUTE Program: today and tomorrow
• Novel stent design and Biomimicry in DES

Live Case Commentator:
Live cases from Bonn, Germany

Rom, 14. - 15. Februar 2013

Fajadet J, Garcia E, Hildick-Smith D,  Petronio S, Silber S, Neumann FJ, Zaman A,  Wöhrle J, Spence M, Elhadad S
on behalf of the Platinum Plus Trial Investigators
A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients: PLATiNUM PLUS
1 month results
TCT (Transcatheter Cardiovascular Therapeutics) 
Miami, October 2012
Poster Presentation

XXXIV Congresso DA SBHCI 2012
Novas fronteiras - O tratamento do doença arterial coronariana com balao farmacológico
Vortrag: Vaelentines Trial I. o balão farmacologico é uma opção ao BMS e DES nos casos restenose intra stent?
Salvador, Brasil, 20. June 2012

TCT Russia
Chair: Use of DES in Specific Clinical Scenarios
Moderator: Thrombus Management in STEMI- MGuard™ Late Breaking Data.
Moderator: Emerging Coronary Devices
Presentation: Clinical update on Paclitaxel-coated balloon formulations: are there alternatives to lopromide-based coatings?
Moskow, Russia, 28. - 30. Mai 2012

ACS MasterClass Munich:
Presentation: The 2010 ESC Guidelines on Myocardial Revascularization:
A critical review
Munich, 7th of July 2011

XXI. Workshop of Interventional Cardiology:
Presentation: The Resolute Clinical Programme: Current Status
Hradec Králové, Czech Republic, 8. April 2011

RSICA Congress:
Plenary Session: "New generation of DES, DEB and Bioabsorbable stents".
Vortrag: As an Interventional Cardiologist, which DES would you like to have in your arteries?Plenary Session: Modern Interventional Cardiology and Angiology
Vortrag: Evolution in management of in-stent-restenosis. DEB.
Moskow, Russia, 21. March 2011

Cardiology Update 2011
Revascularisation, ACS, Antithrombotics
Satellite Symposium
Presentation: Convincing New Stent Developments
Davos, Switzerland, 17. February 2011

Symposium:
JIM - Joint Interventional Meeting
Live Case Commentator
Life Cases from Milan, Italy
Life Cases from Essen, Germany
Rome, Italy, 10.-11. Februayr 2011

ICI Congress
Drug Eluting Balloons
Chairman:
Drug Eluting Balloons (cont.)
Presentation: Dior in Coronary Intervention 
Lunch Symposium: MGuard, New Evidence in Acute MI
Panel
Regulation in the Changing Economic and Ethical Environment 
Presentation: DES: New Recommendations of the ESC
Tel Aviv, Israel, 7. December 2010

EuroPCR Symposium
What do Resolute All Comers Data tell us about the treatment of complex patients and complex lesions?
Chairman,
Presentation: Challenges in treating complex lesions: What answers does the Resolute All Comers trial provide?
Paris, France, 27. May 2010

Euro PCR
Evening Symposium
MGuard - two Years Experience in Acute MI
Panel
Paris, France, 26. May 2010

59th ESCVS International Congress
in conjunction with the 6th Congress of update in Cardiology and Cardiovascular Surgery - Heart and Health Foundation of Turkey (HHFT)
Lunch Symposium 
IAIC Session
Drug Eluting Stents: A new paradigm in interventionell cardiology
Presentations:

• Transferability of data between different drug eluting stens
• STEMI: Early intervention-Thrombus aspiration 

Izmir, Turkey, 17. April 2010

ACC
Coronary Artery Disease
Panel Discussion
Atlanta, USA, 14. March 2010

Great Minds 
Presentation: DES state of the art
How valid are the data from randomised trials and how applicable are they for nes DES platforms?
Istanbul, Turkey, 30. October 2009

EL CONGRESO OE LAS ENFERMEDADES CARDIOVASCULARES
FOCUS EN EL DIAGNÖSTICO Y TRATAMIENTO OE LAS ENFERMEDADES CORONARIAS / FOCUS ON THE DIAGNOSIS ANO TREATMENT OF CORONARY HEART 0/SEASES
Vortrag: ?Ha cambiado el planteamiento de Ia revascularizaciön coronaria tras los recientes ensayos clfnicos? I Has the Approach to Coronary Revascularization Changed after Recent Clinical Trials?
Barcelona, Spain, 22. October 2009

ESC Congress
Clinical Seminar
What every cardiologist should know about drug-eluting stents
Presentation: Current indications for drug-eluting stents.
Barcelona, Spain, 1. September 2009

ESC Congress
Clinical Seminar, Webcast
Take home messages for practitioners
In collaboration with the Council for Cardiology Practice
Presentation: Risk stratification and coronary heart disease.
Barcelona, Spain, 1. September 2009

ESC Congress
Focus Session
Percutaneous Coronary Intervention: Antithrombotic Therapy
Chairperson
Barcelona, Spanien, 30 August 2009

CARDIOLOGISK VA
Jointsymposium ESC Council of Cardiology Practice/Privat Praktiserende Kardialogers ForumjNorwegian Society of Cardiology
Presentation: When to re(re-)revascularize or have the COURAGE to defer another angio? Are the ACCF /SCAI/STS/ AAlS/ AHA/ ASNC 2009 appropriateness criteria for revascularization applicable to European practice for chronic stable angina?
Tromsø, Norway, 18. June 2009

EuroPCR
ACC-i2 Summit @ EuroPCR – Unresolved/poorlyaddressed issues: ACC and EuroPCR/EAPCI intiatives Under the auspices of the American College
Co-chairperson
Presentation: Introduction and objectives
Roundtable discussion
Barcelona, Spain, 21. May 2009

ACC
Vascular Access and Closure
Panel
Presentation: New Generation Closure Devices: An Update
Orlando, USA, 29. March 2009

JIM
Case study 1. Pharmacology and stent decision in STEMI intervention
Vortrag: Case 1. A high risk STEMI patient
Vortrag: Case conclusion and discussion
Lunch Symposium
Hot Topics 2
Presentation: Transferability of data between different drug-eluting stens
Rome, Italy, 12. - 13. February 2009

The 5th International Cardiac Congress of Saud Al-Babtain Cardiac Center
Coronary Artery Disease in Diabetic Patients
Chair
Coronary Artery Disease in Diabetic Patients
Chair
Live Case
Presentation: How to choose DES in DM?
Dammam, Saudi Arabia, 13. January 2009

The 5th International Cardiac Congress of Saud Al-Babtain Cardiac Center
and
The 20th Scientific Session of the Saudi Heart Association
Chair
Al-Khobar, Saudi Arabia, 12.-15. January 2009

ESC - Acute Cardiac Care
Advanced percutaneous coronary interventions
Presentation: Pros and cons of thrombectomy devices in STEMI.
Versailles, France; 28. October 2008

SOLACI
DES Summit I
Presentation: Update on Taxus Trials
Meeting the Clinical Cardiologist I
Presentation: Calcium Scoring makes senese for primary prevention
DES: Update and Perspectives (Evening Symposium)
Presentation: Evidence-Based Medicine
Case-Based Crossfire Discussion
Presentation: Diabetic Patient with Multiple Vessel Disease. Take-Home Message
Cancun, Mexico, 6. - 8. August 2008

The 17th Annual Meeting of the Japenese Society of Interventional Cardiology (17th JSIC)
President Invited Lecture
Presentation: Can PCI exceed bypass surgery?
-What improvement is needed to exceed bypass surgery- (tentative)
Presentation: TAXUS Express 2 Stent Post Marketing Surveillance Results of initaial clinical follwo up (tentative)
Japan, 3. - 5. Juli 2008

British Cardiovascular Society
Annual Scientifi Conference
British Cardiovascular Society (BCS)
European Society Cardiology (ESC)
British Cardiovascular Intervention Society (BCIS)
Guidelines: Development and Deliverance
Presentation: PCI Guidelines - how we do it
Manchester, UK, 3. Juni 2008

EuroPCR
Drug-eluting stents in challenging palients and lesions
Chair: Objeclive: To review the evidence far using specific drug-eluting stents far challenging patients and lesian types
Take home message
Symposium: When safety meets efficacy - Nobori drug-eluting stent
Presentation: Nobori 1 results update
TCT@ EuroPCR - Hottopics in intervenlional cardiology 
Under the auspices ot the Transcatheter Cardiovascular Therapeutics (TCT)
Chair
Barcelona, Spain, 13. - 16. Mai 2008

ICI
CURRENT PROBLEMS IN DRUG ELUTING STENTS
Presentation: DES Efficacy - Safety Balance - The Right to Choose
Tel Aviv, Israel, 3. December 2007

ESC 
Abstract Session
Trials and registries in percutaneous coronary intervention
Chair
Symposium
Implementation of ESC practice guidelines for percutaneous coronary interventions in Europe - impact on longterm outcome. Lessons of the Euro Heart Survey Programme
Vortrag: Long-term outcome of PCI in multi-vessel disease.
Abstract Session/Poster Session 5
Presentation: Value of Cardiac CT in Addition to Myocardial Perfusion Szintigraphy.
Take home messages for practitioners
» Clinical Seminar In collaboration with the Council for Cardiology Practice«
Presentation: Risk stratification and coronary artery disease.
Vienna, Austria,  2. - 4. September 2007

ESC
Abstract:
Final 5-year clinical follow-up of TAXUS II: long-term anti-restenotic efficacy and safety for both slow- and moderate-release polymer-based, paclitaxel-eluting TAXUS stents
Vienna, Austria, September 2007

ESC
Abstract
Value of Cardiac CT in Additon to Myocardial Perfusion Szintigraphie
Vienna, Austria,  September 2007

ESC
Abstract
Gender differences in the application and outcome of PCI, Euro Heart Survey PCI
Vienna, Austria, September 2007

talking eyes&more
International Symposium
Cardiovascular Prevention - "State of the Art"
Presentation: “Evidence-based identification of high-risk patients in primary prevention of coronary artery disease” 
Nuremberg, 26. May 2007

EuroPCR 
Late breaking coronary trials
Panel
Take home message
Coronary drug-eluting stents: current questions, future perspectives
Presentation: Debate on duration of dual antiplatelet therapy: 6-month antiplatelet post-coronary drug-eluting stent
Optimising coronary drug-eluting stent results in diabetics
Chair
Presentation: Introduction and learning objectives
Take home message
Percutaneous coronary intervention in acute and later phase of myocardial infarction
Presentation: Do we need to update the guidelines?
22/23/24. May 2007

ACC Roundtable
Topical Issues with Drug Eluting Stents
Co-Chair
New Orleans, USA, 26. März 2007

ACC
Drug Eluting Stent Revolution IV
Presentation: DES Safety vs. Efficacy: Diverse Viewpoints on the Appropriate Utilization of DES, BMS and CABG
Presentation: Evidence-Based Medicine Indications for DES Usage: European Recommendations
Roundtable Discussion and Audience Q&A: Selection of DES vs. BMS vs. Surgery
Presentation: Back to the Patient: A Case-Based Forum
Presentation: The Case III: Diffuse Multivessel Disease (Type II Diabetes)
New Orleans, USA, 23. März 2007

ICI
New Stent Technologies: Raising the Bar on Clinical Outcomes
Panel
Presentation: The Role of Drug Eluting Stents (DES) in Acute Myocardial Infarction with ST-segment Elevation (STEMI)
Tel Aviv, Israel, 4. December 2006

AHA
A New Stainless-Steel-Free Stent with a Potential of Artifact-Free Magnetic Resonance Compatibility: First Clinical Experience
Poster
Chicago, USA, 12. November 2006

TCT
Clinical Trials
Abstract: First Five-Year Clinical Follow-Up from a Randomized Trial of a Polymer-Based, Paclitaxel-Eluting Stent: TAXUS I
Washington DC, USA, 23. Oktober 2006

ESC
Experts of the Take-Home Session
Presentation: Coronary artery disease
Barcelona, Spain, 4. September 2006

EuroPCR
Opening symposium: The Great Debate on drug-eluting stents
Panel
Late breaking trials and clinical trial updates
How to critically analyse randomised trials and registries
Synthesis and implication for practice
Presentations
Percutaneous cardiovascular intervention in Europe: looking towards the future
Panel
Vortrag: How to actively involve the National Working Groups
New diagnostic approaches in patients with suspected coronary artery disease
Panel
The role of a healing stent: safety is mandatory
Chair
CRT @ EuroPCR
Presentation: How to select commercialy available drug-eluting stents: based on guidelines
EuroPCR, 16/17/18. May 2006

ACC Summit 2006
Live Case Transmission Session II
Panel
Percutaneous Coronary Intervention Guidelines
Presentation: European Percutaneous Coronary Intervention Guidelines
Atlanta, USA, 12. - 14. March, 2006

6th International Symposium on Cardiovascular Interventions
3. Coronary Interventions
Presentation: Different DES in complex lesions - are the clinical results still the same?
6. Peripheral Artery Interventions
Satellite Symposium
Presentation: Are all DES the same?
Kitzbühel, Austria, 20. February 2006

Spanish Society of Cardiology
Invited Speaker:
Outpatient Treatment of Heart Failure
Barcelona, Spain, 26. October 2005

TCT
Session III Updates on Current Device Options: Devices Description, Data and Optimal Technique
Moderator
Presentation: Duett balloon occlusion with an external biological procoagulant
Controversies in ACS, AMI and PCI Treatment Pathways: Reconciling the Guidelines
Co-Moderator
Section I. Optimal Treatment for the Patient with STEMI Presenting at a Noninterventional Facility: Drip and/or Ship?
Presentation: Review of the data
Panel discussion and audience Q&A
Discussant
Section IV. Thrombectomy and Distal Protection Devices in ACS and AMI
Panel discussion and audience Q&A
Discussant
Live-Case Session
Live Case Discussant
Session II. Studies with New Bare Metal Stents
Presentation: Featured lecture. Results with two niobium/iridium oxide stents
Session III: TCT Abstracts
Discussant
Washington, USA, 16 bis 21. October 2005

ESC
New practice guidelines of the Europeans Society of Cardiology
Presentation: Percutaneous coronary intervention
Stockholm, Sweden,4. September 2005

Munich Symposium on Interventional Cardiology
Vortrag: Contemporary use of arterial closure diveices
Brachytherapie
Chair
Munich, 11/12. Oktober 2002

ESC Congress
Council of Cardiology Practice
Present and Future of Cardiology by Practising Cardiologists
Vortrag: What can be done as a practising cardiologist? Coronary angiography and interventions.
Berlin, 3. September 2002

ESC Congress
Recent clinical trial update I
Coronary disease and Arrhythmias
Vortrag: START: two years follow up
Berlin, 2. September 2002

ESC Congress
Cardiac Computed Tomography: Something new on the horizon?
Vortrag: The MUNICH registry: "normal" distribution of coronary artery calcium measured by 4-slice computed tomography in over 2000 asymptomatic individuals.
Berlin, 1. September 2002